Moderna, Inc. (MRNA)
254.19
+12.73
(+5.27%)
USD |
NASDAQ |
Nov 06, 16:00
256.94
+2.75
(+1.08%)
After-Hours: 20:00
Moderna Total Long Term Debt (Quarterly) : 4.206B for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 4.206B |
| June 30, 2026 | 1.266B |
| March 31, 2026 | 1.279B |
| December 31, 2025 | 1.288B |
| September 30, 2025 | 717.00M |
| June 30, 2025 | 725.00M |
| March 31, 2025 | 730.00M |
| December 31, 2024 | 733.00M |
| September 30, 2024 | 1.334B |
| June 30, 2024 | 1.244B |
| March 31, 2024 | 1.212B |
| December 31, 2023 | 1.218B |
| September 30, 2023 | 1.422B |
| June 30, 2023 | 1.134B |
| March 31, 2023 | 1.08B |
| December 31, 2022 | 1.165B |
| September 30, 2022 | 1.225B |
| June 30, 2022 | 849.00M |
| March 31, 2022 | 901.00M |
| Date | Value |
|---|---|
| December 31, 2021 | 870.00M |
| September 30, 2021 | 561.00M |
| June 30, 2021 | 592.00M |
| March 31, 2021 | 279.00M |
| December 31, 2020 | 231.62M |
| September 30, 2020 | 207.56M |
| June 30, 2020 | 167.77M |
| March 31, 2020 | 147.85M |
| December 31, 2019 | 132.36M |
| September 30, 2019 | 33.80M |
| June 30, 2019 | 33.59M |
| March 31, 2019 | 41.14M |
| December 31, 2018 | 43.99M |
| September 30, 2018 | 26.89M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 15.69M |
| September 30, 2017 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 1.202B |
| Vaxcyte, Inc. | 215.14M |
| Twist Bioscience Corp. | 84.96M |
| BioNTech SE | 359.16M |
| Vir Biotechnology, Inc. | 81.46M |